U.S. flag

An official website of the United States government

NM_001360.3(DHCR7):c.852C>A (p.Phe284Leu) AND Inborn genetic diseases

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 18, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002442731.2

Allele description [Variation Report for NM_001360.3(DHCR7):c.852C>A (p.Phe284Leu)]

NM_001360.3(DHCR7):c.852C>A (p.Phe284Leu)

Gene:
DHCR7:7-dehydrocholesterol reductase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.4
Genomic location:
Preferred name:
NM_001360.3(DHCR7):c.852C>A (p.Phe284Leu)
HGVS:
  • NC_000011.10:g.71437923G>T
  • NG_012655.2:g.15509C>A
  • NM_001163817.2:c.852C>A
  • NM_001360.3:c.852C>AMANE SELECT
  • NP_001157289.1:p.Phe284Leu
  • NP_001351.2:p.Phe284Leu
  • NP_001351.2:p.Phe284Leu
  • LRG_340t1:c.852C>A
  • LRG_340:g.15509C>A
  • LRG_340p1:p.Phe284Leu
  • NC_000011.9:g.71148969G>T
  • NM_001360.2:c.852C>A
Note:
ClinGen staff contributed the HGVS expression for this variant.
Protein change:
F284L; PHE284LEU
Links:
OMIM: 602858.0019; dbSNP: rs184297154
NCBI 1000 Genomes Browser:
rs184297154
Molecular consequence:
  • NM_001163817.2:c.852C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001360.3:c.852C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002676747Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Oct 18, 2017)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.

Witsch-Baumgartner M, Fitzky BU, Ogorelkova M, Kraft HG, Moebius FF, Glossmann H, Seedorf U, Gillessen-Kaesbach G, Hoffmann GF, Clayton P, Kelley RI, Utermann G.

Am J Hum Genet. 2000 Feb;66(2):402-12.

PubMed [citation]
PMID:
10677299
PMCID:
PMC1288092

Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome.

Yu H, Lee MH, Starck L, Elias ER, Irons M, Salen G, Patel SB, Tint GS.

Hum Mol Genet. 2000 May 22;9(9):1385-91. Erratum in: Hum Mol Genet 2000 Jul 22;9(12):1903.

PubMed [citation]
PMID:
10814720
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV002676747.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The p.F284L variant (also known as c.852C>A), located in coding exon 6 of the DHCR7 gene, results from a C to A substitution at nucleotide position 852. The phenylalanine at codon 284 is replaced by leucine, an amino acid with highly similar properties. This variant was identified in a female infant with Hirschsprung disease, dysmorphic features including mild ptosis, short nose with anteverted nares, long philtrum, micrognathia, 2-3 toe syndactyly, and elevated 7-dehydrocholesterol levels; this variant was identified in conjunction with a second DHCR7 alteration (Yu H et al. Hum. Mol. Genet., 2000 May;9:1385-91; Mueller C et al. Am. J. Med. Genet. A, 2003 Nov;123A:100-6). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024